knowledge landing page image

KWM Advised Ant Financial on Its Series C USD 14 Billion Equity Financing

News - China

KWM Advised Ant Financial on Its Series C USD 14 Billion Equity Financing

King & Wood Mallesons (KWM) acted as the legal counsel to Ant Financial and Ant International for both the RMB tranche and the USD tranche of this project,...

08 June 2018

King & Wood Mallesons advises Foxconn Industrial Internet Co., Ltd. on its successful A-share listing

In this project, KWM acted for FII as the PRC and Hong Kong SAR counsel, and advised on the restructuring, implementing, reforming and various aspects of the issuance...

08 June 2018

KWM assists Weichai Power to enter into equity investment and framework agreements with Ceres Power

King & Wood Mallesons’ cross-border team advised Weichai Power ("Weichai") one of China’s leading automobile and equipment manufacturing companies.

29 May 2018

King& Wood Mallesons patent team continuously ranked top tier by MIP

King& Wood Mallesons IP team was ranked top tier in both patent prosecution and patent contentious.

16 May 2018

Shifting from quantity to quality in China's trademark protection

Last year saw a new record-breaking achievement by Chinese trademarks, with over 5.7 million applications filed, which amounts to over 80 percent of the total increase of worldwide...

15 May 2018

Luye Pharma Group (listed in Hong Kong) and AstraZeneca enter US$546 million agreement for rights to Seroquel and Seroquel XR in the UK, China and other international markets

King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the...

09 May 2018